Trinity Point Wealth, LLC Novo Nordisk A S Transaction History

Trinity Point Wealth, LLC

$680 Million
Q3 2024

A detailed history of Trinity Point Wealth, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Trinity Point Wealth, LLC holds 16,353 shares of NVO stock, worth $1.69 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

16,353

Previous 18,131 9.81%

Holding current value

$1.69 Million

Previous $2.59 Million 24.77%

% of portfolio

0.29%

Previous 0.41%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$119.07 - $145.42 $211,706 - $258,556	-1,778 Reduced 9.81%	16,353 $1.95 Million
Q2 2024 Jul 30, 2024	SELL	$122.71 - $146.91 $79,638 - $95,344	-649 Reduced 3.46%	18,131 $2.59 Million
Q1 2024 May 08, 2024	SELL	$102.11 - $135.92 $1,837 - $2,446	-18 Reduced 0.1%	18,780 $2.41 Million
Q4 2023 Feb 08, 2024	SELL	$87.78 - $105.45 $127,983 - $153,746	-1,458 Reduced 7.2%	18,798 $1.94 Million
Q3 2023 Nov 08, 2023	BUY	$90.94 - $199.54 $809,275 - $1.78 Million	8,899 Added 78.36%	20,256 $1.84 Million
Q2 2023 Aug 07, 2023	SELL	$155.98 - $172.65 $146,777 - $162,463	-941 Reduced 7.65%	11,357 $1.84 Million
Q1 2023 May 04, 2023	SELL	$132.34 - $159.14 $143,456 - $172,507	-1,084 Reduced 8.1%	12,298 $1.96 Million
Q4 2022 Feb 07, 2023	SELL	$102.55 - $135.33 $61,222 - $80,792	-597 Reduced 4.27%	13,382 $1.81 Million
Q3 2022 Nov 09, 2022	BUY	$95.28 - $116.93 $76,319 - $93,660	801 Added 6.08%	13,979 $1.39 Million
Q2 2022 Aug 05, 2022	SELL	$103.24 - $121.81 $67,725 - $79,907	-656 Reduced 4.74%	13,178 $1.47 Million
Q1 2022 May 13, 2022	SELL	$93.1 - $112.54 $17,223 - $20,819	-185 Reduced 1.32%	13,834 $1.54 Million
Q4 2021 Feb 11, 2022	SELL	$95.88 - $117.08 $16,587 - $20,254	-173 Reduced 1.22%	14,019 $1.57 Million
Q3 2021 Nov 12, 2021	SELL	$84.42 - $106.62 $133,468 - $168,566	-1,581 Reduced 10.02%	14,192 $1.36 Million
Q2 2021 Aug 13, 2021	BUY	$67.66 - $84.76 $23,681 - $29,666	350 Added 2.27%	15,773 $1.32 Million
Q1 2021 May 11, 2021	SELL	$67.06 - $75.82 $38,894 - $43,975	-580 Reduced 3.62%	15,423 $1.04 Million
Q4 2020 Feb 10, 2021	BUY	$63.89 - $73.8 $30,667 - $35,424	480 Added 3.09%	16,003 $1.17 Million
Q3 2020 Nov 13, 2020	SELL	$63.69 - $70.22 $15,285 - $16,852	-240 Reduced 1.52%	15,523 $1.08 Million
Q2 2020 Aug 13, 2020	SELL	$58.54 - $67.94 $70,365 - $81,663	-1,202 Reduced 7.09%	15,763 $1.03 Million
Q1 2020 May 05, 2020	BUY	$49.46 - $64.78 $35,363 - $46,317	715 Added 4.4%	16,965 $1.02 Million
Q4 2019 Feb 06, 2020	SELL	$49.86 - $58.26 $119,763 - $139,940	-2,402 Reduced 12.88%	16,250 $941,000
Q3 2019 Nov 07, 2019	BUY	$47.54 - $53.43 $886,716 - $996,576	18,652 New	18,652 $1.06 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $233B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trinity Point Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trinity Point Wealth, LLC with notifications on news.

Account

Trinity Point Wealth, LLC Novo Nordisk A S Transaction History